Press News

Press News

Press News | 25.02.2026

Print:
Title Media Publ. Date
Spyros Sapounas: Overconsumption of antibiotics Apogevmatini 25/02/2026
Why don’t breakthrough medicines reach Greece? Apogevmatini 25/02/2026
Companies in the U.S. are seeking compensation for the tariffs Kathimerini 25/02/2026
Dimitris Dentakis: The value of contributing, even to a single patient Kathimerini 25/02/2026

 

See here the publicity

 

Web Monitoring Report for the period 24/02 – 25/02

Title Media Publ. Date
Clinical trials: Now is the time for Europe to act – Benefits for 35,000 patients and the economy cnn.gr 24/02/2026
E. Agapidaki: 5.4 million unique beneficiaries, out of a total of 6 million under the National “Prolamvano” Program, have undergone the examinations ertnews.gr 24/02/2026
Greek pharma innovation faces bleak future, industry wants “urgent changes” euractiv.com 24/02/2026
Adonis Georgiadis: “I expect more medicine withdrawals from the market” healthreport.gr 25/02/2026
D. Papageorgiou (Takeda): Innovation is not sustainable with these rebates – How will therapies reach patients in time? healthstories.gr 24/02/2026
Clinical trials deliver remarkable added value for Europe in.gr 25/02/2026
Key points from the interview of Minister of Health Adonis Georgiadis on the program “Ataíriastoi” on SKAI TV moh.gov.gr 24/02/2026
Target for an 11% increase in clinical trials in Europe – An additional €4 billion for healthcare systems newsbomb.gr 24/02/2026
WHO Europe: On March 3, the “Quality for All” platform will be presented at the MoH parapolitika.gr 24/02/2026
National Plan needed for the holistic care of rare disease patients ygeiamou.gr 25/02/2026

RELATED NEWS

Skip to content